Interleukin inhibitors for psoriatic arthritis

1Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate benefits and harms of interleukin inhibitors for the treatment of psoriatic arthritis (PsA).

Cite

CITATION STYLE

APA

Sharma, G., Mudano, A. S., & Singh, J. A. (2018). Interleukin inhibitors for psoriatic arthritis. Cochrane Database of Systematic Reviews, 2018(6). https://doi.org/10.1002/14651858.CD013043

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free